Dallas, TX: ReportsandReports announce it will carry Taiwan In Vitro Diagnostics Market Outlook to 2016 Market Research Report in its Store.

Browse complete Taiwan In Vitro Diagnostics Market Outlook to 2016 Report

GlobalData’s new report, “Taiwan In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Taiwan In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for In Vitro Diagnostics (IVD) market categories clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
• 2009 company shares and distribution shares data for each of the seven market categories.
• Global corporate-level profiles of key companies operating within the Taiwan In Vitro Diagnostics (IVD) market.
• Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Taiwan In Vitro Diagnostics (IVD) competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1.1 List of Tables 9

1.2 List of Figures 12

2 Introduction 15

2.1 What is This Report About? 15

3 In Vitro Diagnostics In Taiwan 16

3.1 In Vitro Diagnostics, Market Segmentation 16

3.2 In Vitro Diagnostics, Taiwan, Overall Revenue ($m), 2002-2016 17

3.3 In Vitro Diagnostics Market, Taiwan, Revenue Mix ($m), 2009 19

3.4 In Vitro Diagnostics Market, Taiwan, Category Contribution (%), 2009 20

3.5 In Vitro Diagnostics, Taiwan, Company Share (2008-2009) 26

4 Clinical Chemistry In Taiwan 28

4.1 Clinical Chemistry, Market Segmentation 28

4.2 Clinical Chemistry Market, Taiwan, Revenue Mix ($m), 2009 29

4.3 Clinical Chemistry Market, Taiwan, Category Contribution (%), 2009 30

4.4 Clinical Chemistry Overall Revenue (2002-2016) 31

4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016) 35

4.4.2 Urine Analysis Revenue (2002-2016) 39

4.5 Clinical Chemistry Distribution Share (2008-2009) 43

4.6 Clinical Chemistry, Taiwan, Company Share (2008-2009) 44

5 Genetic Testing In Taiwan 46

5.1 Genetic Testing, Market Segmentation 46

5.2 Genetic Testing Market, Taiwan, Revenue Mix ($m), 2009 47

5.3 Genetic Testing Market, Taiwan, Category Contribution (%), 2009 48

5.4 Genetic Testing Overall Revenue (2002-2016) 49

5.5 Genetic Testing Distribution Share (2008-2009) 53

5.6 Genetic Testing, Taiwan, Company Share (2008-2009) 54

6 Haematology In Taiwan 55

6.1 Haematology, Market Segmentation 55

6.2 Haematology Market, Taiwan, Revenue Mix ($m), 2009 56

6.3 Haematology Market, Taiwan, Category Contribution (%), 2009 57

6.4 Haematology Overall Revenue (2002-2016) 58

6.4.1 Haematology Reagents Revenue (2002-2016) 62

6.4.2 Immunohaematology Revenue (2002-2016) 65

6.4.3 Haemostasis Revenue (2002-2016) 67

6.4.4 Haematology Rapid Tests Revenue (2002-2016) 71

6.4.5 Haematology Cell Counters Revenue (2002-2016) 74

6.5 Haematology Distribution Share (2008-2009) 76

6.6 Haematology, Taiwan, Company Share (2008-2009) 77

7 Histology And Cytology In Taiwan 79

7.1 Histology and Cytology, Market Segmentation 79

7.2 Histology and Cytology Market, Taiwan, Revenue Mix ($m), 2009 80

7.3 Histology and Cytology Market, Taiwan, Category Contribution (%), 2009 81

7.4 Histology and Cytology Overall Revenue (2002-2016) 82

7.4.1 Histology Revenue (2002-2016) 85

7.5 Histology And Cytology Distribution Share (2008-2009) 88

7.6 Histology And Cytology, Taiwan, Company Share (2008-2009) 89

8 Immuno Chemistry In Taiwan 90

8.1 Immuno Chemistry, Market Segmentation 90

8.2 Immuno Chemistry Market, Taiwan, Revenue Mix ($m), 2009 91

8.3 Immuno Chemistry Market, Taiwan, Category Contribution (%), 2009 92

8.4 Immuno Chemistry Overall Revenue (2002-2016) 93

8.4.1 Disease Specific Immunochemistry Revenue (2002-2016) 97

8.4.2 Drug Related Testing Revenue (2002-2016) 101

8.4.3 Endocrinology Tests Revenue (2002-2016) 103

8.4.4 Immunochemistry Analyzers Revenue (2002-2016) 107

8.5 Immuno Chemistry Distribution Share (2008-2009) 111

8.6 Immuno Chemistry, Taiwan, Company Share (2008-2009) 112

9 Infectious Immunology In Taiwan 114

9.1 Infectious Immunology, Market Segmentation 114

9.2 Infectious Immunology Market, Taiwan, Revenue Mix ($m), 2009 115

9.3 Infectious Immunology Market, Taiwan, Category Contribution (%), 2009 116

9.4 Infectious Immunology Overall Revenue (2002-2016) 117

9.5 Infectious Immunology Distribution Share (2008-2009) 121

9.6 Infectious Immunology, Taiwan, Company Share (2008-2009) 122

10 Microbiology Culture In Taiwan 124

10.1 Microbiology Culture, Market Segmentation 124

10.2 Microbiology Culture Market, Taiwan, Revenue Mix ($m), 2009 125

10.3 Microbiology Culture Market, Taiwan, Category Contribution (%), 2009 126

10.4 Microbiology Culture Overall Revenue (2002-2016) 127

10.4.1 Microbiology Analyzers Revenue (2002-2016) 131

10.5 Microbiology Culture Distribution Share (2008-2009) 133

10.6 Microbiology Culture, Taiwan, Company Share (2008-2009) 134

11 Overview of Key Companies in Taiwan In Vitro Diagnostics Market 135

11.1 F. Hoffmann-La Roche Ltd. 135

11.1.1 Company Overview 135

11.1.2 Share in the Taiwan In Vitro Diagnostics Market 135

11.2 Siemens Healthcare 136

11.2.1 Company Overview 136

11.2.2 Share in the Taiwan In Vitro Diagnostics Market 136

11.3 Beckman Coulter, Inc. 137

11.3.1 Company Overview 137

11.3.2 Share in the Taiwan In Vitro Diagnostics Market 137

11.4 Ortho-Clinical Diagnostics Inc. 138

11.4.1 Company Overview 138

11.4.2 Share in the Taiwan In Vitro Diagnostics Market 138

11.5 Abbott Laboratories 139

11.5.1 Company Overview 139

11.5.2 Share in the Taiwan In Vitro Diagnostics Market 139

11.6 bioMerieux S.A. 140

11.6.1 Company Overview 140

11.6.2 Share in the Taiwan In Vitro Diagnostics Market 140

11.7 Inverness Medical Innovations, Inc. 141

11.7.1 Company Overview 141

11.8 Becton, Dickinson and Company 141

11.8.1 Company Overview 141

11.9 Bio-Rad Laboratories, Inc. 142

11.9.1 Company Overview 142

11.10 Hologic, Inc. 142

11.10.1 Company Overview 142

11.11 OLYMPUS CORPORATION 143

11.11.1 Company Overview 143

11.12 Mindray Medical International Limited 143

11.12.1 Company Overview 143

11.13 Sysmex Corporation 144

11.13.1 Company Overview 144

11.14 Ventana Medical Systems, Inc. 144

11.14.1 Company Overview 144

11.15 DiaSorin S.p.A 144

11.15.1 Company Overview 144

11.16 Qiagen N.V. 145

11.16.1 Company Overview 145

11.17 Gen-Probe Incorporated 145

11.17.1 Company Overview 145

11.18 Phadia AB 145

11.18.1 Company Overview 145

11.19 BioCare Corporation 146

11.19.1 Company Overview 146

11.20 AsiaGen Corporation 146

11.20.1 Company Overview 146

11.21 Oncoprobe Biotech Inc. 146

11.21.1 Company Overview 146

11.22 Exploit Technologies Pte Ltd 147

11.22.1 Company Overview 147

11.23 Apex Biotechnology Corp. 147

11.23.1 Company Overview 147

11.24 Health & Life Co., Ltd. 147

11.24.1 Company Overview 147

11.25 Eumed Biotechnology Co., Ltd. 148

11.25.1 Company Overview 148

11.26 Vita Genomics, Inc. 148

11.26.1 Company Overview 148

11.27 Formosa Biomedical Technology Corp. 148

11.27.1 Company Overview 148

12 In Vitro Diagnostics Market Pipeline Products 149

12.1 Clinical Chemisty Market Pipeline Products 149

12.2 Immuno Chemistry Market Pipeline Products 151

12.3 Haematology Market Pipeline Products 152

12.4 Infectious Immunology Market Pipeline Products 153

12.5 Microbiology Culture Market Pipeline Products 155

12.6 Histology and Cytology Market Pipeline Products 156

12.7 Genetic Testing Market Pipeline Products 157

13 Financial Deals Landscape 159

13.1 Partnerships 159

13.1.1 QIAGEN Enters Into Distribution Agreement With Celera 159

13.1.2 Sequenom Enters Into Licensing Agreement With Optherion 160

13.1.3 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 161

13.1.4 TriLink BioTechnologies Enters Into Distribution Agreement With Nacalai USA 162

13.1.5 OraSure Technologies Enters Into An Agreement With Roche Diagnostics 163

13.1.6 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 164

13.1.7 DxS Signs Cross-Licensing Agreement With Epigenomics 165

14 Appendix 166

14.1 Definitions of Markets Covered in the Report 167

14.1.1 In Vitro Diagnostics 167

14.2 Research Methodology 174

14.3 Secondary Research 175

14.4 Primary Research 175

14.5 Models 176

14.6 Forecasts 176

14.7 Expert Panels 176

14.8 GlobalData Consulting 176

14.9 Currency Conversion 177

14.10 Contact Us 177

14.11 Disclaimer 177

Browse complete Taiwan In Vitro Diagnostics Market Outlook to 2016 Report

Browse all Medical Devices Market Research Reports

Browse all GlobalData Market Research Reports

Browse all Latest Report

Related Reports:

Taiwan Diagnostic Imaging Market Outlook to 2016

South Africa In Vitro Diagnostics Market Outlook to 2016

Japan In Vitro Diagnostics Market Outlook to 2016

About Us:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/
Blog: http://reportsandreports.blogspot.com/